338 results on '"Daali, Y."'
Search Results
2. PB0011 Evaluation of the Association between Clinical Events and Apixaban/ Rivaroxaban’s Plasma exposure in Patients from the OptimAT Study
3. Influence of the paraoxonase‐1 Q192R genetic variant on clopidogrel responsiveness and recurrent cardiovascular events: a systematic review and meta‐analysis
4. Drug metabolic enzyme genotype-phenotype discrepancy: High phenoconversion rate in patients treated with antidepressants
5. The association of cytochrome P450 genetic polymorphisms with sulfolane formation and the efficacy of a busulfan-based conditioning regimen in pediatric patients undergoing hematopoietic stem cell transplantation
6. Antiplatelet Therapy: Targeting the TxA2 Pathway
7. Influence des polymorphismes génétiques sur la variabilité de la réponse aux opioïdes
8. Utilisation des analgésiques dans l’insuffisance hépatique
9. Intérêt des outils d’investigation des enzymes métaboliques en pratique clinique
10. Applications of CYP450 Testing in the Clinical Setting
11. Development and validation of a chemical hydrolysis method for dextromethorphan and dextrophan determination in urine samples: Application to the assessment of CYP2D6 activity in fibromyalgia patients
12. Geneva Cocktail for Cytochrome P450 and P-Glycoprotein Activity Assessment Using Dried Blood Spots
13. The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype prediction
14. Aspirin response: how to explain striking differences in serum TxB2 levels across clinical studies and what use for serum TxB2?: PB 3.21–4
15. Simultaneous analysis of polyhydroxylated alkaloids by capillary electrophoresis using borate complexation and evaluation of sweeping technique for sensitivity improvement
16. Liver kidney microsomal type 1 antibodies reduce the CYP2D6 activity in patients with chronic hepatitis C virus infection
17. The paraoxonase-1 pathway is not a major bioactivation pathway of clopidogrel in vitro
18. Oral Flurbiprofen Metabolic Ratio Assessment Using a Single-Point Dried Blood Spot
19. Two structurally different T-type Ca2+ channel inhibitors, mibefradil and pimozide, protect CA1 neurons from delayed death after global ischemia in rats
20. RITONAVIR INHIBITS PRASUGREL IN VITRO BIOACTIVATION: A POTENTIAL PHARMACOKINETIC INTERACTION: P289
21. Modern approaches for the phenotyping of cytochrome P450 enzymes in children
22. The effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodone
23. Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safety
24. Development and validation of a new reversed-phase ion pairing liquid chromatographic method with fluorescence detection for penciclovir analysis in plasma and aqueous humor
25. DIFFERENTIAL TRANSPORT OF OPIOIDS, NMDA ANTAGONIST AND THEIR ACTIVE METABOLITES MAY INFLUENCE THEIR ANALGESIC EFFICACY: 653
26. SIGNIFICANCE OF GENETIC AND NEUROPHYSIOLOGICAL ASPECTS IN FIBROMYALGIA: 420
27. Not all statins interfere with clopidogrel during antiplatelet therapy
28. P83 CYP2D6 phenotyping in children treated with tramadol at the Emergency Department
29. Routine o-glycan characterization in nutritional supplements — a comparison of analytical methods for the monitoring of the bovine kappa-casein macropeptide glycosylation
30. Gabaa Subtypes-Selective Modulation: A Novel Mechanism-Based Approach to the Treatment of Neuropathic Pain
31. Impact of (CYP3A Inhibiting) Antiretroviral Treatment on the Pharmacokinetics and Pharmacodynamics of Clopidogrel and Prasugrel
32. Impact of Functional Allelic Variations on Drug-Drug Interactions Involving CYP2D6
33. Why Has Model‐Informed Precision Dosing Not Yet Become Common Clinical Reality? Lessons From the Past and a Roadmap for the Future
34. Why has model-informed precision dosing not yet become common clinical reality? lessons from the past and a roadmap for the future
35. Coadministration of ticagrelor and ritonavir: Toward prospective dose adjustment to maintain an optimal platelet inhibition using the PBPK approach
36. Innovative approach to Blood sampling using dried Blood spots. application to Pharmacokinetics and Cytochrome P450 Phenotyping
37. Evaluation of CYP450 and transporters expression and activity in heparg cell line under different conditions
38. Vincristine-Induced Neuropathic Pain In A Cyp3a5 Non-Expresser With Reduced Cyp3a4 Activity
39. Screening for phenotypical variation in CYP activity in patients with therapeutic problem in psychiatric settings
40. In-vitro evaluation of DDI with cobicistat and ritonavir using heparg cell line
41. Prediction of Metabolic Interactions With Oxycodone via CYP2D6 and CYP3A Inhibition Using a Physiologically Based Pharmacokinetic Model
42. Role of paraoxonase-1 in CYP2C19 loss-of-function carriers
43. Antiplatelet Therapy: Targeting the TxA2 Pathway
44. The association of cytochrome P450 genetic polymorphisms with sulfolane formation and the efficacy of a busulfan-based conditioning regimen in pediatric patients undergoing hematopoietic stem cell transplantation
45. PP121—CYP2C9 genotypes associated with higher sulfolane levels in children receiving intravenous busulfan prior to hematopoietic stem cell transplantation
46. PP269—Interest of genotype assessment in antidepressant treatment failure in psychiatric patients: A case report
47. PP175—Evidence of Drug–Drug Interactions Through Uptake and Efflux Transport Systems in Rat Hepatocytes: Implications For Cellular Concentrations Of Competing Drugs
48. Oc013 — A Simplified Method For Busulfan Therapeutic Drug Monitoring Using Dried Blood Spot Sampling In Pediatric Patient Undergoing Stem Cell Transplantation
49. PP233—CYP1A activity after chronic exposure to dioxins from a waste incinerator
50. PP193—Simultaneous LC-MS/MS Quantification of P-Glycoprotein and Cytochrome P450 Probe Substrates and Their Metabolites In Dried Blood Spots
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.